FindMyKOL
Clinical trialNCT02441829CompletedPhase 1Interventional

Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function

SponsorGilead SciencesEnrollment55Long QT Syndrome
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will evaluate the pharmacokinetics (PK), safety, and tolerability of a single oral dose of eleclazine and its metabolite, GS-623134, in participants with normal and impaired renal function. Participants in the healthy control group will be matched to participants with impaired renal function by age (± 5 years), gender, and body mass index (± 10%).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Moldova
  • Facility name not stated

    Chisinau, Moldova

Romania
  • Facility name not stated

    Bucharest, Romania

United States
  • Facility name not stated

    DeLand, Florida, United States

  • Facility name not stated

    Miami, Florida, United States

  • Facility name not stated

    Orlando, Florida, United States

  • Facility name not stated

    Saint Paul, Minnesota, United States

  • Facility name not stated

    Kansas City, Missouri, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Eleclazine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2015
Primary completion
31 Dec 2015
Completion
31 Dec 2015
Last update posted
22 Dec 2015
Registered enrollment
55
Registry id
NCT02441829

Cross-registrations

EU-CTR / CTIS (EudraCT)2014-005267-32
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.